HIV Immunoglobulin (HIVIG)

HIV immunoglobulin · National Heart, Lung, and Blood Institute (NHLBI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV Immunoglobulin (HIVIG), covering 2016-04-14 to 2016-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) [Phase 3]

See pricing